Taiwan FDA granted the peptide API Market License of Octreotider Acetate "GBC"
Taiwan FDA granted the in-house developed the peptide Active Pharmaceutical Ingredient Market License of Octreotider Acetate "GBC", Registration Number: MOHW-PM061159 (DMF No. : DMF(00)4145)
